Journal ID (nlm-ta): PLoS One
Journal ID (iso-abbrev): PLoS One
Journal ID (publisher-id): plos
Title:
PLOS ONE
Publisher:
Public Library of Science
(San Francisco, CA USA
)
ISSN
(Electronic):
1932-6203
Publication date
(Electronic):
27
April
2023
Publication date Collection: 2023
Publication date PMC-release: 27
April
2023
Volume: 18
Issue: 4
Electronic Location Identifier: e0282806
Affiliations
Gabriele d’Annunzio University of Chieti and Pescara: Universita degli Studi Gabriele
d’Annunzio Chieti Pescara, ITALY
Author notes
Competing Interests: I have read the journal’s policy and the following authors of this manuscript have
declared that no competing interests exist: JGH, CKJ, PB, TGK, FIK, ANAA, SLM, BLJ,
BBB, CS, TLN, LVH, BLM, AB, ME, PHB, EMJP, GBE, AMD, AS, IHMM, NZJ, PTP, MPGJ, TIP,
RE, HESSR, MB, US, HA, MRS, PS, SA, JUSJ, KB, KMJ, MJSK, TL, UVS, MGA, SR, NlD, PR,
NR, DP, AK, SJ, LEK, CL, BBH, OK, SRO, STS, AP, NK, MSP, LS, MV, LEC, MS AC, JF, AF,
JW, RL, MR, TL, CR and TKF. I have read the journal’s policy and the following authors
of this manuscript have following competing interests: ZBH has received research grants
from Independent Research Fund Denmark (grant nr. 0134-00257B) and Lundbeck Foundation
(grant nr. R349-2020-835). MvW was partially supported by the Independent Research
Fund Denmark (grant # 8020-00284), and Carlsberg Foundation, Semper Ardens Research
Project (grant # CF20-0046). LN received travel grants from MSD, GSK and Gilead. TB
has received grants from Novo Nordisk Foundation, Lundbeck Foundation, Simonsen Foundation,
GSK, Pfizer, Gilead, Kai Hansen Foundation and Erik and Susanna Olesen’s Charitable
Fund and personal fees from GSK, Pfizer, Boehringer Ingelheim, Gilead, MSD, Pentabase
ApS, Becton Dickinson, Janssen and Astra Zeneca, all outside the submitted work.
¶ Membership of the COVID-19 Omicron Delta study group is listed in the Acknowledgments.
Article
Publisher ID:
PONE-D-22-23300
DOI: 10.1371/journal.pone.0282806
PMC ID: 10138229
PubMed ID: 37104488
SO-VID: d3119762-d6b2-482f-b1d7-82ae0772d042
Copyright © © 2023 COVID-19 Omicron Delta study group
License:
This is an open access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided
the original author and source are credited.
The authors received no specific funding for this work.
Subject:
Research Article
Subject:
Medicine and Health Sciences
Subject:
Medical Conditions
Subject:
Infectious Diseases
Subject:
Viral Diseases
Subject:
Covid 19
Subject:
Biology and Life Sciences
Subject:
Immunology
Subject:
Vaccination and Immunization
Subject:
Medicine and Health Sciences
Subject:
Immunology
Subject:
Vaccination and Immunization
Subject:
Medicine and Health Sciences
Subject:
Public and Occupational Health
Subject:
Preventive Medicine
Subject:
Vaccination and Immunization
Subject:
Biology and life sciences
Subject:
Organisms
Subject:
Viruses
Subject:
RNA viruses
Subject:
Coronaviruses
Subject:
SARS coronavirus
Subject:
SARS CoV 2
Subject:
Biology and life sciences
Subject:
Microbiology
Subject:
Medical microbiology
Subject:
Microbial pathogens
Subject:
Viral pathogens
Subject:
Coronaviruses
Subject:
SARS coronavirus
Subject:
SARS CoV 2
Subject:
Medicine and health sciences
Subject:
Pathology and laboratory medicine
Subject:
Pathogens
Subject:
Microbial pathogens
Subject:
Viral pathogens
Subject:
Coronaviruses
Subject:
SARS coronavirus
Subject:
SARS CoV 2
Subject:
Biology and life sciences
Subject:
Organisms
Subject:
Viruses
Subject:
Viral pathogens
Subject:
Coronaviruses
Subject:
SARS coronavirus
Subject:
SARS CoV 2
Subject:
Medicine and Health Sciences
Subject:
Medical Conditions
Subject:
Infectious Diseases
Subject:
Infectious Disease Control
Subject:
Vaccines
Subject:
Medicine and Health Sciences
Subject:
Diagnostic Medicine
Subject:
Virus Testing
Subject:
Medicine and Health Sciences
Subject:
Health Care
Subject:
Health Care Facilities
Subject:
Hospitals
Subject:
Medicine and Health Sciences
Subject:
Epidemiology
Subject:
Medical Risk Factors
Subject:
Cancer Risk Factors
Subject:
Medicine and Health Sciences
Subject:
Oncology
Subject:
Cancer Risk Factors
Subject:
Medicine and Health Sciences
Subject:
Epidemiology
Subject:
Medical Risk Factors